Martin Martinot
Martin Martinot is an expert in Infectiology at Hopitaux Civils de Colmar (France). As of October 2026, ScienceLeadR ranks Martin Martinot in the top 1% of experts worldwide for Coronavirus Infections, COVID-19 and Pneumonia. Martin Martinot has authored 218 publications, the most recent in 2026, and is an investigator in 12 clinical trials, 1 of them ongoing. SLR score: 687 (community average: 125). How the SLR is computed.
LeadR Profile
Infectiology
Subspecialties: Neurology - Hematology - Internal Medicine
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1999 - 2026
Number : 218
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Combined pneumonia and glandular tularemia following a tick bite in an immunocompromised patient. PMID 42824551 — tularemia, pneumonia, immunocompromised host, tick bites | IDCases | 2026 | 0 |
| COVID-19 in nursing homes: What syndromic and virological surveillance revealed about the first two epidemic waves. PMID 42668659 — research design, mortality, immunization, disease outbreaks, nursing, nursing homes, covid-19, sentinel surveillance, epidemics | J Infect Prev | 2026 | 0 |
| Long-term prognosis of patients surviving progressive multifocal leukoencephalopathy. PMID 42314166 — mortality, leukoencephalopathy, progressive multifocal, leukoencephalopathies, diagnosis, neurology, prognosis, functional status | Brain | 2026 | 0 |
| Recurrent aseptic meningitis in adults: a potential indicator of undetermined autoinflammatory disease. PMID 42199401 — meningitis, aseptic, meningitis, signs and symptoms, immune system diseases, diagnosis, therapeutics | Front Immunol | 2026 | 0 |
| High Nasopharyngeal SARS-CoV-2 Load and Delayed Clearance in Hospitalized Patients With Blood Autoantibodies Neutralizing Type I Interferons. PMID 42053985 — autoantibodies, sars-cov-2, blood, viral load, interferon type i, severe acute respiratory syndrome-related coronavirus, communicable diseases | J Infect Dis | 2026 | 0 |
Clinical Studies 12
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Cohort/Consortium Investigators 27
Ongoing Clinical Trials
Ongoing trial started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| TIBOLA Multicenter Descriptive Study in Eastern France NCT05458245 — spotted fever group rickettsiosis, rickettsia infections, rickettsia, tick-borne diseases, infections | N/A | Recruiting | 2022 |
LeadR Networks
Main global connection map